This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: C4 Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Robert T. Yu
Introduction
Robert T. Yu is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on developing compounds that specifically target and degrade BRAF, a protein that plays a crucial role in the growth of certain cancers.
Latest Patents
Robert T. Yu holds 1 patent for his invention related to BRAF degraders. This patent presents compounds that cause the degradation of BRAF, offering potential therapeutic benefits for various types of cancer. The specificity of these compounds makes them a promising avenue for targeted cancer therapies.
Career Highlights
Yu is currently employed at C4 Therapeutics, Inc., a company dedicated to advancing targeted protein degradation as a therapeutic strategy. His work at C4 Therapeutics reflects his commitment to innovative solutions in the fight against cancer.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues, including Mark E. Fitzgerald and Christopher G. Nasveschuk. These collaborations have likely contributed to the advancement of his research and the development of effective cancer treatments.
Conclusion
Robert T. Yu's contributions to the field of cancer research through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for new therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile